Yu Nakamura

Miki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Correction: Relationship Between Wechsler Intelligence Scale for Children-IV Profiles and School Refusal in Children With Autism Spectrum Disorder.

Correction: Relationship Between Wechsler Intelligence Scale for Children-IV Profiles and School Refusal in Children With Autism Spectrum Disorder.

Journal: Cureus

Published: August 14, 2026

Relationship Between Wechsler Intelligence Scale for Children-IV Profiles and School Refusal in Children With Autism Spectrum Disorder.

Relationship Between Wechsler Intelligence Scale for Children-IV Profiles and School Refusal in Children With Autism Spectrum Disorder.

Journal: Cureus

Published: May 28, 2026

Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With Mild-to-Moderate Alzheimer Disease.

Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With Mild-to-Moderate Alzheimer Disease.

Journal: Alzheimer disease and associated disorders

Published: April 19, 2026

Efficacy and safety of a novel, extended-release rivastigmine transdermal patch (TW-4752N) in patients with Alzheimer's disease: A 24-week randomized, double-blind trial with a 28-week open-label extension.

Efficacy and safety of a novel, extended-release rivastigmine transdermal patch (TW-4752N) in patients with Alzheimer's disease: A 24-week randomized, double-blind trial with a 28-week open-label extension.

Journal: Journal of Alzheimer's disease : JAD

Published: December 09, 2025

Female-biased vulnerability to transgenerational impact of paternal early-life stress.

Female-biased vulnerability to transgenerational impact of paternal early-life stress.

Journal: Psychoneuroendocrinology

Published: November 13, 2025

Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's dementia.

Brexpiprazole's impacts on patients and caregivers in agitation in Alzheimer's dementia.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 28, 2025

Long-term safety and tolerability of brexpiprazole for Japanese patients with agitation in Alzheimer's disease dementia: A multicenter, open-label study.

Long-term safety and tolerability of brexpiprazole for Japanese patients with agitation in Alzheimer's disease dementia: A multicenter, open-label study.

Journal: Journal of Alzheimer's disease reports

Published: November 25, 2024

Efficiency of Skeletal Muscle Mass/Weight Measurement for Distinguishing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Analysis Using InBody Bioimpedance Devices.

Efficiency of Skeletal Muscle Mass/Weight Measurement for Distinguishing Metabolic Dysfunction-Associated Steatotic Liver Disease: A Prospective Analysis Using InBody Bioimpedance Devices.

Journal: Nutrients

Published: October 27, 2024

Effect of Social Restriction Due to the COVID-19 Pandemic on Activity of Daily Living and Disease Severity of Patients With Alzheimer Disease: Sub-analysis of a Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets.

Effect of Social Restriction Due to the COVID-19 Pandemic on Activity of Daily Living and Disease Severity of Patients With Alzheimer Disease: Sub-analysis of a Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets.

Journal: Alzheimer disease and associated disorders

Published: August 18, 2024

Effect of Social Isolation Due to the COVID-19 Pandemic on Cognitive Dysfunction of Patients With Alzheimer Disease: Subanalysis of Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets.

Effect of Social Isolation Due to the COVID-19 Pandemic on Cognitive Dysfunction of Patients With Alzheimer Disease: Subanalysis of Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets.

Journal: Alzheimer disease and associated disorders

Published: July 07, 2024

Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study.

Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 17, 2024

Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease.

Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: September 18, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026